-
Abstract Number: PB1789
M1 Protein from Group A Streptococcus Regulates Fibrin Clot Formation, Structure and Fibrinolytic Potential
-
Abstract Number: PB/CO13
Macrovascular Thrombotic Events in a Mayo Clinic Enterprise-wide Sample of Hospitalized COVID-19 Positive Compared to Negative Patients
-
Abstract Number: PB1977
MADD Regulates von Willebrand Factor Trafficking in Endothelial Cells via Activation of Weibel-Palade Body-Associated Rab GTPases
-
Abstract Number: PB0788
Major Bleeding after a Gynecological Operation in Patient with Thrombocytosis and Anemia: Acquired von Willebrand Syndrome?
-
Abstract Number: PB2463
Major Bleeding Complications from Direct Oral Anticoagulants in Thai Adult Patients
-
Abstract Number: PB0885
Major Surgery in Emicizumab Haven 1 Trial Patients: The New Zealand Experience
-
Abstract Number: PB2406
Management and Outcomes Following Subsegmental Pulmonary Embolism: Single Centre Experience at King’s College Hospital
-
Abstract Number: PB2390
Management and Outcomes of Idiopathic Axillosubclavian Vein Thrombosis: Impact of the Treating Specialty
-
Abstract Number: PB1278
Management and Outcomes of Newborns at Risk for Inherited Antithrombin Deficiency at the Karolinska University Hospital, Stockholm, Sweden
-
Abstract Number: PB2503
Management of a Pregnancy in a Woman with Hypodysfibrinogenemia: An Experiment in Strasbourg
-
Abstract Number: PB2408
Management of Acute Venous Thromboembolism in Patients Taking Antiplatelet Therapy: A Bi-Center Analysis
-
Abstract Number: PB2056
Management of DOACs in Elective Surgery Procedures: A Measurement Based Approach
-
Abstract Number: PB1019
Management of Hemostatic Balance in Elective Joint Replacement Surgery in Patients with Haemophilia
-
Abstract Number: PB2404
Management of Intermediate-High Risk Pulmonary Embolism Utilizing a PE Response Team
-
Abstract Number: PB0314
Management of Intracranial Hemorrhage in Patients under Non-vitamin K Antagonist Oral Anticoagulants
-
Abstract Number: PB2572
Management of Pregnancy in Severe Factor V Deficiency in Women with Varying Phenotypes
-
Abstract Number: PB1382
Management of Steroid Refractory Acute Immune Thrombocytopenia Purpura – A Single Center Experience from India
-
Abstract Number: PB2569
Management of Thrombocytopenia in Obstetric Patients: A Retrospective Teaching Hospital Experience
-
Abstract Number: PB2308
Management Strategies and Clinical Outcomes in Patients with Inferior Vena Cava Thrombosis: Data from the GARFIELD-VTE Registry
-
Abstract Number: PB2453
Management Strategy of Venous Thrombosis in a Dialysis Patient with History of Heparin Induced Thrombocytopenia
-
Abstract Number: PB2237
Mandor´s Disease: A Manifestation of Rare Conditions
-
Abstract Number: PB1162
Marzeptacog Alfa (Activated) Population PK: Simulations for Dose Selection in Phase 3 Trials
-
Abstract Number: PB2122
Massive Life-Threatening Intravascular Tumor Thrombus (ITT) as the Initial Manifestation of Renal Cell Carcinoma Complicated with Heparin-Induced Thrombocytopenia: A Case Study
-
Abstract Number: PB2541
Maternal Carriage of the Annexin A5 M2 Haplotype Combined with Inherited or Acquired Thrombophilia Would Synergistically Increase the Risk of Suffering Intra Uterine Growth Restriction
-
Abstract Number: PB0142
Maternal Deficiency of Endothelial Protein C Receptor Causes Severe Pregnancy Complications Prevented by Inactivation of Protease Activated Receptor 4, but not Clotting Factor VIII
-
Abstract Number: OC 09.1
Maternal Microchimerism Protects Hemophilia A Patient from Inhibitor Development
-
Abstract Number: PB1713
Maternal Platelet Function Altered by Cigarette Smoking in Early Pregnancy
-
Abstract Number: PB2507
Maternal Thrombocytopenia in Women Initiating Antenatal Care: A Hospital-Based Study
-
Abstract Number: PB2470
May Thurner Syndrome, Experience on Argentinean Hospital
-
Abstract Number: PB2533
Mean Platelet Volume from Adolescent to Adult and during Pregnancy
-
Abstract Number: PB1697
Mean Platelet Volume, and Not Platelet Aggregation, Is Associated with Diabetes: Population Studies from 3,000 to 463,000 Individuals
-
Abstract Number: PB0225
Measurement of Polyphosphate in Biologic Samples
-
Abstract Number: PB1587
Measurement of VWF:FVIII Binding (VWF:FVIIIB) in a Cohort of Patients with Suspected Type 2N VWD and Correlation with Genetic Analysis of the VWF Gene
-
Abstract Number: PB2203
Measuring Functional Limitations after Venous Thromboembolism: Optimization of the Post-VTE Functional Status (PVFS) Scale
-
Abstract Number: PB1017
Measuring the Impact of Hemophilia on Families
-
Abstract Number: PB0603
Measuring Thrombin Generation in the Presence of Haemoglobin on the ST Genesia
-
Abstract Number: PB1964
Mechanisms and Functional Consequences of Platelet-derived Extracellular Vesicle and Chemokine Internalisation by Endothelial Cells
-
Abstract Number: PB0356
Mechanisms of Blood Clotting Activation by Amniotic Fluid
-
Abstract Number: PB1095
Mechanistic Evaluation of Factor IX-Padua Activity in Chromogenic FIX and Thrombin Generation Assays
-
Abstract Number: PB1606
Megakaryocyte Mitochondrial Dynamics and Oxidative Metabolism Are Essential to Initiate Platelet Biogenesis
-
Abstract Number: PB2003
Megakaryocytes Are Reprogrammed by Lipopolysaccharide Exposure during Bacterial Sepsis
-
Abstract Number: PB1596
Megakaryocytes Possess a Functional Necroptosis Pathway
-
Abstract Number: PB1316
Megakaryocytic Hyperplasia in Bone Marrow Biopsy as a Novel Predictor of Response in Patients with Immune Thrombocytopenia
-
Abstract Number: PB1201
Menorrhagia in Egyptian Adolescents with Inherited Bleeding Disorders: A Single Centre Study
-
Abstract Number: PB1673
Mepacrine Uptake & Release Assay in Thrombocytopenic Patients
-
Abstract Number: PB1601
Mesenchymal Stromal Cells Display Metabolic Alterations in JAK2-Mutant Myeloproliferative Neoplasms
-
Abstract Number: PB0553
Method Comparison of Eight Coagulation Assays on the Cobas t 411 versus Cobas t 511/t 711 Analysers
-
Abstract Number: PB1466
Method of Anticoagulation Influences Potency of Reversible P2Y12 Receptor Antagonists
-
Abstract Number: PB1122
Methodological and Reporting Quality in Case Series of Four-Factor Prothrombin Complex Concentrate in the Management of Oral Factor Xa Inhibitor-Associated Bleeding
-
Abstract Number: PB0842
Methodological Validation of the Measurement of Ultra-low Levels of Factor VIII Activity by Chronometric APTT-based Assay
-
Abstract Number: PB0766
Microlyse: A VWF-Targeting Thrombolytic Agent for Thrombotic Thrombocytopenic Purpura
-
Abstract Number: PB0364
Micropartical-Associated Thrombin Generation in Patients with Philadelphia-Negative Myeloproliferative Neoplasms
-
Abstract Number: PB0365
Microparticles Contribute to Hypercoagulation, but Not to Coagulation in Healthy Controls
-
Abstract Number: PB1643
Microparticles Released from Stored Platelet Increase Coagulation Ability
-
Abstract Number: PB2025
Microrna-365a-3p, a Novel Modulator of Tissue Factor Protein Expression and Function
-
Abstract Number: PB1913
MicroRNAs as Potential Biomarkers in Thrombotic Primary Antiphospholipid Syndrome
-
Abstract Number: PB0299
Microstructural Characterisation of in vivo Paediatric ECMO Circuit Binding and Blood Clot Structure
-
Abstract Number: PB2515
Microvesicles, Fibrinolytic and Coagulation Biomarkers in Blood from Pregnant Women
-
Abstract Number: PB1707
Migraine in Patent Foramen Ovale Patients: Role of Platelet Activation
-
Abstract Number: PB2020
mir-146a Deficiency Promotes Neutrophil Aging and Increases their Sensitivity to Form Neutrophil Extracellular Traps (NETs) in a Murine Model
-
Abstract Number: PB0066
MiR-146a Mediates Neutrophil Extracellular Traps Formation in Acute Myocardial Infarction (AMI) in Young Patients
-
Abstract Number: PB2024
MiR-146a Regulates Platelet Function and Thrombosis
-
Abstract Number: PB1630
MiR-204-5p Regulates Platelet Adhesion to Fibrinogen
-
Abstract Number: PB0366
miRNAs 126 and 223 in Microparticles from Patients with Coronary Ischemic Disease
-
Abstract Number: PB1204
Missense Mutations and Predicted Effects on Splicing in Factor XI Deficiency
-
Abstract Number: PB1931
Mixing Studies in Lupus Anticoagulant Tests: A Useful Tool at the Time of Analysis
-
Abstract Number: PB1794
ML355 Inhibits Platelets via GC Activation and Blocks Caspase-Dependent Apoptosis in Platelets
-
Abstract Number: PB1082
Mode of Delivery in Haemophilia: Vaginal Delivery and Cesarean Section Carry Similar Risk for Inhibitor Development in Severe Haemophilia A
-
Abstract Number: PB0849
Modelling the Cost of Equivalent trough Level across Gene Therapy and Factor IX Replacement Therapy in Haemophilia B
-
Abstract Number: PB1243
Moderate Intensity Aerobic Exercise and Intranasal Desmopressin Additively Increase Factor VIII and von Willebrand Factor (VWF) Levels in Adolescent Males with Mild Hemophilia A – Principal Findings from a Randomized Trial
-
Abstract Number: OC 04.1
Moderate Platelet Defects but Efficiently Restored Thrombopoietin Production Early after Partial Hepatectomy via JAK2-STAT3 Signaling in Mice
-
Abstract Number: PB1045
MOdern Treatment of Inhibitor-PositiVe PATiEnts with Haemophilia A – MOTIVATE
-
Abstract Number: PB0555
Modified Anti-Xa Assay for Measuring Betrixaban (Bevyxxa®) Activity in Plasma on STA-R Max
-
Abstract Number: PB1638
Modified Plasma Recalcification Assay for Evaluation of Platelet Procoagulant Activity
-
Abstract Number: PB1795
Modulation of ABT-737 Induced Platelet Apoptosis by Curcumin
-
Abstract Number: PB1189
Modulation of Alternative Splicing of the F5 Gene Using Morpholino Antisense Oligonucleotides
-
Abstract Number: PB0741
Modulation of Thrombin Generation or Thrombin Activity on Activated Platelets Surface Largely Affected TAFI-Dependent Regulation of Fibrinolysis
-
Abstract Number: PB0191
Molecular Analysis in 12 factor XI Deficiency Patients from China: Identification of Three Novel Splicing Mutations
-
Abstract Number: PB0858
Molecular Analysis of Factor VIII Genes in Patients with Hemophilia A; Identification of Specific Mutation in Colombian Patients with Inhibitors
-
Abstract Number: PB1187
Molecular Diagnosis of Quantitative and Qualitative Fibrinogen Deficiencies: A Portuguese Centre Experience
-
Abstract Number: PB1508
Molecular Insights into Glanzmann’s Thrombasthenia through Family Forums for Gene Sequencing and Discovery
-
Abstract Number: PB1036
Molecular Mechanisms Underlying Haemophilia A and B Expression in 7 Females
-
Abstract Number: PB0472
Molecular Pathogenesis of Bone Degenerative Disease and Associated Inflammatory and Thrombotic Processes
-
Abstract Number: PB0591
Monitorig of Direct Oral Anticoagulants in Routine Practice
-
Abstract Number: PB0320
Monitoring and Pharmacodynamic Effect of Eftrenonacog-Alfa (Alprolix®) in Severe Hemophilia B Patients: A Real-Life Study
-
Abstract Number: PB1223
Monitoring of Adverse Event of INR>6 Using IHI Global Trigger Tool in Cardiology Hospital, Pakistan
-
Abstract Number: PB0643
Monitoring of Different FVIII Replacement Drugs Using the FVIII One-stage Clotting Assay on Cobas t 511/711 Analyzers
-
Abstract Number: PB0973
Monitoring of Hemlibra Prophylaxis in Children – Real World Data
-
Abstract Number: PB1525
Monitoring Recombinant and Plasma-Derived VWF Concentrates: An in vitro Study
-
Abstract Number: PB0059
Monitoring the Safety and Effectiveness of Antiplatelet Therapy
-
Abstract Number: PB/CO20
Monitoring Unfractionated Heparin Using PTT Versus Anti-Xa in Veno-venous Extracorporeal Membrane Oxygenation Patients with COVID-19 Infection
-
Abstract Number: PB1379
Monoclonal Antibody Immobilization of Megakaryocyte Antigens (MAIMA) Assay: A Novel Tool for Detecting Human Platelet Antigens
-
Abstract Number: PB1907
Monocyte Activation and Acquired Protein S Deficiency Promote Disseminated Intravascular Coagulation in a Patient with Antiphospholipid Antibodies
-
Abstract Number: PB2071
More Precise Dosing of Acenocoumarol for Better Control in Patients Aged above 80 Years, a Randomized Controlled Pilot Study
-
Abstract Number: PB1952
Morphological and Functional Alterations of Platelets from Transgenic APP23 Mice at Early Alzheimer Disease State
-
Abstract Number: PB1309
Moyamoya Disease – A European Clinical Case Report
-
Abstract Number: PB1091
Multi-Centre Field Study of One-Stage and Chromogenic Factor IX Assays in Samples Containing the Factor IX Padua Variant
-
Abstract Number: PB0733
Multi-ethnic Whole Genome Sequence Analysis of Plasma Fibrinogen in over 150,000 Samples
-
Abstract Number: PB0539
Multicentre Performance Evaluation and Reference Range Determination for a New Assay for the Quantitative Evaluation of Factor VIII in Citrated Plasma
-
Abstract Number: PB0559
Multicentre Performance Evaluation and Reference Ranges for a New Assay for Quantitative Determination of von Willebrand Factor (vWF) Activity
-
Abstract Number: PB0564
Multicentre Performance Evaluation and Reference Ranges for the Quantitative Determination of Factors II, V and VII by One-Stage Factor Assay on the Cobas t 711 Analyser
-
Abstract Number: PB0529
Multicentre Performance Evaluation of the Protein C Chromogenic Assay on the Cobas t 711 Analyser
-
Abstract Number: PB1873
Multicentric Multicountry Evaluation of the Fully Automated Adamts13 Activity Assay
-
Abstract Number: PB2314
Multidisciplinary Approach of Deep Venous Thrombosis (DVT) in Vall d’Hebron University Hospital: Two Years’ Experience
-
Abstract Number: PB2518
Multidisciplinary Care of Pregnancies with VWD Improves Rates of Primary Postpartum Hemorrhage
-
Abstract Number: PB0645
Multimer Analysis in von Willebrand Disease Diagnosis: the Experiency of Use
-
Abstract Number: PB0139
Multiple Gene Knockdowns Simultaneously to Study Hemostasis in Zebrafish
-
Abstract Number: PB1441
MYH9-Related Inherited Thrombocytopenia: 14 Newly Diagnosed Chinese Pedigree
-
Abstract Number: PB0019
Myocardial Infarction as a First Symptom of Activated Protein C Resistance Associated to Hyperhomocyteinemia
ISTH 2020 Congress
July 12-14, 2020. Virtual Congress.